Korea Otsuka Pharmaceutical Co., Ltd.
🇰🇷South Korea
Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder
Completed
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2013-10-23
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 3000
- Registration Number
- NCT00216723
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
Efficacy and Safety of Cilostazol for the Indication of CSPS
Completed
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2009-12-17
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 650
- Registration Number
- NCT00216749
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath